Literature DB >> 10670648

A Stat1alpha factor regulates the expression of the human vimentin gene by IFN-gamma.

E S Izmailova1, S R Snyder, Z E Zehner.   

Abstract

Vimentin is an intermediate filament protein normally expressed in cells of mesenchymal origin. Here, we report an increase in vimentin gene transcription induced by the cytokine interferon-y (IFN-gamma). Northern blot analysis and reporter gene assays reveal that IFN-gamma induces vimentin gene transcription in HeLa cells. However, no increase in vimentin mRNA synthesis was observed de novo in MCF-7 cells, which do not already express vimentin. Band shift analysis shows that the Stat1alpha protein mediates vimentin induction by IFN-gamma. A human mutant fibroblast cell line (U3A), which lacks Stat1alpha but expresses vimentin mRNA, yields no increase in vimentin mRNA levels on the addition of IFN-gamma. These results suggest that the induction of vimentin gene expression might be an important part of a complex cellular response to IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670648     DOI: 10.1089/107999000312694

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  3 in total

1.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

Authors:  Yongzhong Wu; Xueping Zhang; Morgan Salmon; Xia Lin; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2006-12-06

2.  The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesis.

Authors:  Morgan Salmon; Zendra E Zehner
Journal:  Differentiation       Date:  2009-02-23       Impact factor: 3.880

3.  Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.

Authors:  Ka Ka Ting; Bruce J Brew; Gilles J Guillemin
Journal:  J Neuroinflammation       Date:  2009-12-10       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.